Additional Details
-
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
University Hospitals Cleveland Medical CenterCleveland OH. 44121View Details -
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Louisiana State University Health ShreveportShreveport LA. 71102View Details -
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Northwestern UniversityChicago IL. 60611View Details -
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Temple University of The Commonwealth System of Higher EducationPhiladelphia PA. 19140View Details -
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Southeastern Research CenterWinston-Salem NC. 27103View Details -
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
AdventHealth OrlandoOrlando FL. 32803View Details -
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
University of Alabama at BirminghamBirmingham AL. 35205View Details -
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
National Jewish HealthDenver CO. 80206View Details -
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
University of MinnesotaMinneapolis MN. 55455View Details -
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
University of KentuckyLexington KY. 40536View Details -
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
University of Michigan - Michigan MedicineAnn Arbor MI. 48109-5360View Details -
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Dignity Health - St. Joseph's Hospital and Medical Center-Norton Thoracic InstitutePhoenix AZ. 85013View Details -
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
CHI Health Creighton University Medical Center - Bergan MercyOmaha NE. 68124View Details -
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
University of Illinois HealthChicago IL. 60612View Details -
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Baylor University Medical CenterDallas TX. 75246View Details -
Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
Indiana University Health Methodist HospitalIndianapolis IN. 46202View Details -
Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis
Snyder Building 480 Ray C. Hunt DriveCharlottesville VA. 22908View Details -
A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment
University of FloridaGainesville FL. 32610View Details -
A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment
Renstar Medical ResearchOcala FL. 34470View Details
